David Hering

in page functions

Vaccines Commercial Officer, Pfizer, USA

David Hering

David Hering is the Vaccines Commercial Officer for Pfizer. In this role Mr Hering leads Global Marketing and Commercial Development for seven inline products and commercialisation efforts of nine pipeline assets across various stages of drug development from preclinical to phase III. He is also responsible for Pfizer’s Alliances Business including the partnership with Gavi.

Prior to joining Pfizer in 2015, Mr Hering spent seven years at Novartis Vaccines, where he was most recently the Head of the North America Region. In this role, he was responsible for the launch of Bexsero®, Novartis’ (GSK’s) licensed meningococcal B vaccine. He also led the transition of Novartis Vaccines to GSK as part of the acquisition announced in April of 2014 and completed in March 2015. During the Ebola epidemic, he was selected by the CEO of Novartis to run a unified Ebola Task Force response and coordinate all activities across several divisions of the company, including internal and external communications, research programmes, grant responses, and negotiations with governments and third parties.

Mr Hering has held positions of increasing responsibility at Novartis Vaccines, including VP of US Marketing, Head Medical Countermeasures (Biodefense franchise), and roles in US Sales, Product Market Access and Government Contracts, and Influenza Marketing. He began his career at Merck in Manufacturing and Finance and at 3M Company in Consumer Product Marketing. He also worked as a Senior Consultant at Keystone Strategy prior to joining Novartis.

Mr Hering earned a BSc in Operations Research and Industrial Engineering from Cornell University’s College of Engineering (USA), and an MBA from Harvard Business School (USA).


close icon

modal window here